|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-1-15
|
|
pubmed:abstractText |
Guidelines for the use of antiretroviral agents for HIV-1 infection recommend combining at least three agents. The toxicity, cost, and complexity of such regimens warrant the search for other options.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1473-5571
|
|
pubmed:author |
pubmed-author:ChauvinJean-PierreJP,
pubmed-author:Cohen-CodarIsabelleI,
pubmed-author:DelaugerreConstanceC,
pubmed-author:DelfraissyJean-FrançoisJF,
pubmed-author:FlandrePhilippeP,
pubmed-author:GhosnJadeJ,
pubmed-author:GirardPierre-MariePM,
pubmed-author:HorbanAndrzejA,
pubmed-author:NortonMichaelM,
pubmed-author:RouziouxChristineC,
pubmed-author:TaburetAnne-MarieAM,
pubmed-author:VanPhilippe NgoPN
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
30
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
385-93
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:18195565-Adult,
pubmed-meshheading:18195565-Anti-HIV Agents,
pubmed-meshheading:18195565-Drug Resistance, Viral,
pubmed-meshheading:18195565-Drug Therapy, Combination,
pubmed-meshheading:18195565-Female,
pubmed-meshheading:18195565-HIV Infections,
pubmed-meshheading:18195565-HIV Protease,
pubmed-meshheading:18195565-HIV-1,
pubmed-meshheading:18195565-Humans,
pubmed-meshheading:18195565-Lamivudine,
pubmed-meshheading:18195565-Lopinavir,
pubmed-meshheading:18195565-Male,
pubmed-meshheading:18195565-Pyrimidinones,
pubmed-meshheading:18195565-RNA, Viral,
pubmed-meshheading:18195565-Reverse Transcriptase Inhibitors,
pubmed-meshheading:18195565-Ritonavir,
pubmed-meshheading:18195565-Treatment Outcome,
pubmed-meshheading:18195565-Viral Load,
pubmed-meshheading:18195565-Zidovudine
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients.
|
|
pubmed:affiliation |
AP-HP, Department of Internal Medicine and Infectious Diseases, Bicetre University Hospital, Le Kremlin-Bicêtre, France. jean-francois.delfraissy@bct.aphp.fr
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial
|
